Perceptive Advisors’s Allena Pharmaceuticals ALNA Stock Holding History

Perceptive Advisors’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-132,300	Closed	-$521K	–	129
2019 Q3	$521K	Hold	132,300	–	–	0.01%	99
2019 Q2	$538K	Hold	132,300	–	–	0.01%	95
2019 Q1	$929K	Hold	132,300	–	–	0.03%	83
2018 Q4	$704K	Sell	132,300 -117,700	-47%	-$1.01M	0.03%	85
2018 Q3	$2.69M	Hold	250,000	–	–	0.07%	82
2018 Q2	$3.26M	Hold	250,000	–	–	0.09%	83
2018 Q1	$2.75M	Hold	250,000	–	–	0.08%	88
2017 Q4	$2.52M	Buy	+250,000	New	+$3.08M	0.08%	86

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return

Perceptive Advisors's ALNA Position: Q4 2019 in Review

Perceptive Advisors sold out of Allena Pharmaceuticals (ALNA) in Q4 2019, closing a stake of 132,300 shares — an estimated $521K sold.

Perceptive Advisors first reported a position in ALNA in Q4 2017 and held it in 8 quarters. The position peaked at $3.26M in Q2 2018. 26 funds tracked by Wall St. Rank hold ALNA as of Q4 2019.

Perceptive Advisors reported no remaining Allena Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Perceptive Advisors sold 132,300 Allena Pharmaceuticals shares in Q4 2019, an estimated $521K.
Perceptive Advisors first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 8 quarters.
Perceptive Advisors's Allena Pharmaceuticals position peaked at $3.26M in Q2 2018.
26 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2019.

Based on Perceptive Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.